The National Cancer Institute (NCI) awarded Emory University a $664,304 Project Grant under CFDA Program 93.393, Cancer Cause and Prevention Research, to investigate the biological and social determinants of psychosocial outcomes in advanced head and neck cancer patients receiving immunotherapy. The research aims to better understand the psychosocial burden, such as fatigue and depression, experienced by this patient population and identify risk factors to inform targeted interventions. Emory University is the primary awardee, and they have subcontracted a portion of the work to the University of Texas MD Anderson Cancer Center to contribute expertise in cancer research and patient care.
Generated 1/28/25, 8:41 AM